Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide - Concepedia

Concepedia

Publication | Open Access

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

DOI Full Paper Access

740

Citations

20

References

2011

Year

Unknown Author(s)

International Journal of Obesity

Abstract

Liraglutide is well tolerated, sustains weight loss over 2 years and improves cardiovascular risk factors.

References

	Year	Citations

Page 1